https://www.live-feeds.com/feed/treasury-s-coins-rule-draft-would-narrow-the-path-for-china-biotech-dealmaking-experts-sayContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/treasury-s-coins-rule-draft-would-narrow-the-path-for-china-biotech-dealmaking-experts-sayhttps://www.live-feeds.com/feed/treasury-s-coins-rule-draft-would-narrow-the-path-for-china-biotech-dealmaking-experts-say#u165029Sat, 31 Oct 2026 07:30:08 +0000The US Department of the Treasury released a Notice of Proposed Rulemaking to expand its Outbound Investment Security Program by sweeping biotechnology into proposed COINS Act restrictions. According to experts, the draft rules narrow the path for China biotech dealmaking by targeting certain investments in sensitive technologies, though the proposal still allows many standalone drug licensing deals to proceed. China has urged the US to halt the proposed expansion of outbound investment curbs. Transaction structure remains critical, as related financing, shared development, and NewCo arrangeme